Receiving COVID-19 vaccine, hospitalization, and outcomes of patients with COVID-19: A prospective study
Despite Iraq having started the COVID-19 vaccine in January 2020, there is no official data on vaccination and hospitalization across the country. We aimed to explore the role of the COVID-19 vaccine on the hospitalization and outcomes of patients with COVID-19 in Iraqi Kurdistan. In this prospecti...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2022-06-01
|
| Series: | Monaldi Archives for Chest Disease |
| Subjects: | |
| Online Access: | https://www.monaldi-archives.org/index.php/macd/article/view/2194 |
| _version_ | 1811332607534694400 |
|---|---|
| author | Deldar Morad Abdulah Abbas Muhammed Sadiq Mirza |
| author_facet | Deldar Morad Abdulah Abbas Muhammed Sadiq Mirza |
| author_sort | Deldar Morad Abdulah |
| collection | DOAJ |
| description |
Despite Iraq having started the COVID-19 vaccine in January 2020, there is no official data on vaccination and hospitalization across the country. We aimed to explore the role of the COVID-19 vaccine on the hospitalization and outcomes of patients with COVID-19 in Iraqi Kurdistan. In this prospective study, patients who were admitted to two COVID-19 hospitals in Iraqi Kurdistan in 2021 were followed-up by the discharge time between August and November 2021. The mean age of the patients was 57.6 (27-98 years) of both genders. Most of the patients were illiterate (69.3%) or had a lower level of education (20.5%). A small percentage of patients had previous thrombotic disorders (4.7%) and close to half of the patients had chronic diseases (44.9%). The patients had mild to moderate (44.9%), moderate-severe (36.2%), and critical (18.9%) status. The median hospitalization day was 9 days (1-45 days). The study found that 91.3% of the COVID-19 hospitalized patients did not receive the vaccine and 26.8% of patients died. We did not find a significant association between receiving vaccination and patients’ outcomes or disease severity. No patients with previous thrombotic disorders received the COVID-19 vaccine. The male patients were more likely to receive the COVID-19 vaccine compared to female patients; 14.55% vs. 4.17%, p=0.0394. This study showed that most patients with COVID-19 who were admitted to the hospitals have not received the COVID-19 vaccine. A high percentage of the COVID-19 hospitalized patients died of the disease in this region.
|
| first_indexed | 2024-04-13T16:39:25Z |
| format | Article |
| id | doaj.art-e07009c5ed454b62923c688330d36b96 |
| institution | Directory Open Access Journal |
| issn | 1122-0643 2532-5264 |
| language | English |
| last_indexed | 2024-04-13T16:39:25Z |
| publishDate | 2022-06-01 |
| publisher | PAGEPress Publications |
| record_format | Article |
| series | Monaldi Archives for Chest Disease |
| spelling | doaj.art-e07009c5ed454b62923c688330d36b962022-12-22T02:39:19ZengPAGEPress PublicationsMonaldi Archives for Chest Disease1122-06432532-52642022-06-0110.4081/monaldi.2022.2194Receiving COVID-19 vaccine, hospitalization, and outcomes of patients with COVID-19: A prospective studyDeldar Morad Abdulah0Abbas Muhammed Sadiq Mirza1Community Health Unit, College of Nursing, University of DuhokAzadi Teaching Hospital and Duhok General Directorate of Health, Iraqi Kurdistan, Duhok Despite Iraq having started the COVID-19 vaccine in January 2020, there is no official data on vaccination and hospitalization across the country. We aimed to explore the role of the COVID-19 vaccine on the hospitalization and outcomes of patients with COVID-19 in Iraqi Kurdistan. In this prospective study, patients who were admitted to two COVID-19 hospitals in Iraqi Kurdistan in 2021 were followed-up by the discharge time between August and November 2021. The mean age of the patients was 57.6 (27-98 years) of both genders. Most of the patients were illiterate (69.3%) or had a lower level of education (20.5%). A small percentage of patients had previous thrombotic disorders (4.7%) and close to half of the patients had chronic diseases (44.9%). The patients had mild to moderate (44.9%), moderate-severe (36.2%), and critical (18.9%) status. The median hospitalization day was 9 days (1-45 days). The study found that 91.3% of the COVID-19 hospitalized patients did not receive the vaccine and 26.8% of patients died. We did not find a significant association between receiving vaccination and patients’ outcomes or disease severity. No patients with previous thrombotic disorders received the COVID-19 vaccine. The male patients were more likely to receive the COVID-19 vaccine compared to female patients; 14.55% vs. 4.17%, p=0.0394. This study showed that most patients with COVID-19 who were admitted to the hospitals have not received the COVID-19 vaccine. A high percentage of the COVID-19 hospitalized patients died of the disease in this region. https://www.monaldi-archives.org/index.php/macd/article/view/2194COVID-19COVID-19 vaccinedisease severityhospitalizationmortality rate |
| spellingShingle | Deldar Morad Abdulah Abbas Muhammed Sadiq Mirza Receiving COVID-19 vaccine, hospitalization, and outcomes of patients with COVID-19: A prospective study Monaldi Archives for Chest Disease COVID-19 COVID-19 vaccine disease severity hospitalization mortality rate |
| title | Receiving COVID-19 vaccine, hospitalization, and outcomes of patients with COVID-19: A prospective study |
| title_full | Receiving COVID-19 vaccine, hospitalization, and outcomes of patients with COVID-19: A prospective study |
| title_fullStr | Receiving COVID-19 vaccine, hospitalization, and outcomes of patients with COVID-19: A prospective study |
| title_full_unstemmed | Receiving COVID-19 vaccine, hospitalization, and outcomes of patients with COVID-19: A prospective study |
| title_short | Receiving COVID-19 vaccine, hospitalization, and outcomes of patients with COVID-19: A prospective study |
| title_sort | receiving covid 19 vaccine hospitalization and outcomes of patients with covid 19 a prospective study |
| topic | COVID-19 COVID-19 vaccine disease severity hospitalization mortality rate |
| url | https://www.monaldi-archives.org/index.php/macd/article/view/2194 |
| work_keys_str_mv | AT deldarmoradabdulah receivingcovid19vaccinehospitalizationandoutcomesofpatientswithcovid19aprospectivestudy AT abbasmuhammedsadiqmirza receivingcovid19vaccinehospitalizationandoutcomesofpatientswithcovid19aprospectivestudy |